2018-2023 Global mRNA Vaccines & Therapeutics Consumption Market Report

September 2018 | 136 pages | ID: 2ABB46462F7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global mRNA Vaccines & Therapeutics market for 2018-2023.

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.
The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.
Over the next five years, LPI(LP Information) projects that mRNA Vaccines & Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Standardization Of Cancer Treatment MRNA Vaccine
• Individualized Cancer Treatment MRNA Vaccine
• Infectious Disease Treatment MRNA Vaccine
• Infection Prevention MRNA Vaccine

Segmentation by application:

• Infectious Disease
• Cancer
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Moderna Therapeutics
• CureVac
• Translate Bio
• BioNTech
• Sangamo Therapeutics
• Argos Therapeutics
• In-Cell-Art
• eTheRNA
• Ethris
• Tiba Biotechnology

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global mRNA Vaccines & Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of mRNA Vaccines & Therapeutics market by identifying its various subsegments.
• Focuses on the key global mRNA Vaccines & Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the mRNA Vaccines & Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of mRNA Vaccines & Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global mRNA Vaccines & Therapeutics Consumption 2013-2023
  2.1.2 mRNA Vaccines & Therapeutics Consumption CAGR by Region
2.2 mRNA Vaccines & Therapeutics Segment by Type
  2.2.1 Standardization Of Cancer Treatment MRNA Vaccine
  2.2.2 Individualized Cancer Treatment MRNA Vaccine
  2.2.3 Infectious Disease Treatment MRNA Vaccine
  2.2.4 Infection Prevention MRNA Vaccine
2.3 mRNA Vaccines & Therapeutics Consumption by Type
  2.3.1 Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2013-2018)
  2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2013-2018)
  2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2013-2018)
2.4 mRNA Vaccines & Therapeutics Segment by Application
  2.4.1 Infectious Disease
  2.4.2 Cancer
  2.4.3 Other
2.5 mRNA Vaccines & Therapeutics Consumption by Application
  2.5.1 Global mRNA Vaccines & Therapeutics Consumption Market Share by Application (2013-2018)
  2.5.2 Global mRNA Vaccines & Therapeutics Value and Market Share by Application (2013-2018)
  2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2013-2018)

3 GLOBAL MRNA VACCINES & THERAPEUTICS BY PLAYERS

3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Players
  3.1.1 Global mRNA Vaccines & Therapeutics Sales by Players (2016-2018)
  3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Players
  3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Players (2016-2018)
  3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global mRNA Vaccines & Therapeutics Sale Price by Players
3.4 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 MRNA VACCINES & THERAPEUTICS BY REGIONS

4.1 mRNA Vaccines & Therapeutics by Regions
  4.1.1 Global mRNA Vaccines & Therapeutics Consumption by Regions
  4.1.2 Global mRNA Vaccines & Therapeutics Value by Regions
4.2 Americas mRNA Vaccines & Therapeutics Consumption Growth
4.3 APAC mRNA Vaccines & Therapeutics Consumption Growth
4.4 Europe mRNA Vaccines & Therapeutics Consumption Growth
4.5 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Growth

5 AMERICAS

5.1 Americas mRNA Vaccines & Therapeutics Consumption by Countries
  5.1.1 Americas mRNA Vaccines & Therapeutics Consumption by Countries (2013-2018)
  5.1.2 Americas mRNA Vaccines & Therapeutics Value by Countries (2013-2018)
5.2 Americas mRNA Vaccines & Therapeutics Consumption by Type
5.3 Americas mRNA Vaccines & Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC mRNA Vaccines & Therapeutics Consumption by Countries
  6.1.1 APAC mRNA Vaccines & Therapeutics Consumption by Countries (2013-2018)
  6.1.2 APAC mRNA Vaccines & Therapeutics Value by Countries (2013-2018)
6.2 APAC mRNA Vaccines & Therapeutics Consumption by Type
6.3 APAC mRNA Vaccines & Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe mRNA Vaccines & Therapeutics by Countries
  7.1.1 Europe mRNA Vaccines & Therapeutics Consumption by Countries (2013-2018)
  7.1.2 Europe mRNA Vaccines & Therapeutics Value by Countries (2013-2018)
7.2 Europe mRNA Vaccines & Therapeutics Consumption by Type
7.3 Europe mRNA Vaccines & Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Countries
  8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Type
8.3 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 mRNA Vaccines & Therapeutics Distributors
10.3 mRNA Vaccines & Therapeutics Customer

11 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET FORECAST

11.1 Global mRNA Vaccines & Therapeutics Consumption Forecast (2018-2023)
11.2 Global mRNA Vaccines & Therapeutics Forecast by Regions
  11.2.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2018-2023)
  11.2.2 Global mRNA Vaccines & Therapeutics Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global mRNA Vaccines & Therapeutics Forecast by Type
11.8 Global mRNA Vaccines & Therapeutics Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Moderna Therapeutics
  12.1.1 Company Details
  12.1.2 mRNA Vaccines & Therapeutics Product Offered
  12.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Moderna Therapeutics News
12.2 CureVac
  12.2.1 Company Details
  12.2.2 mRNA Vaccines & Therapeutics Product Offered
  12.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 CureVac News
12.3 Translate Bio
  12.3.1 Company Details
  12.3.2 mRNA Vaccines & Therapeutics Product Offered
  12.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Translate Bio News
12.4 BioNTech
  12.4.1 Company Details
  12.4.2 mRNA Vaccines & Therapeutics Product Offered
  12.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 BioNTech News
12.5 Sangamo Therapeutics
  12.5.1 Company Details
  12.5.2 mRNA Vaccines & Therapeutics Product Offered
  12.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Sangamo Therapeutics News
12.6 Argos Therapeutics
  12.6.1 Company Details
  12.6.2 mRNA Vaccines & Therapeutics Product Offered
  12.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Argos Therapeutics News
12.7 In-Cell-Art
  12.7.1 Company Details
  12.7.2 mRNA Vaccines & Therapeutics Product Offered
  12.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 In-Cell-Art News
12.8 eTheRNA
  12.8.1 Company Details
  12.8.2 mRNA Vaccines & Therapeutics Product Offered
  12.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 eTheRNA News
12.9 Ethris
  12.9.1 Company Details
  12.9.2 mRNA Vaccines & Therapeutics Product Offered
  12.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Ethris News
12.10 Tiba Biotechnology
  12.10.1 Company Details
  12.10.2 mRNA Vaccines & Therapeutics Product Offered
  12.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Tiba Biotechnology News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of mRNA Vaccines & Therapeutics
Table Product Specifications of mRNA Vaccines & Therapeutics
Figure mRNA Vaccines & Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global mRNA Vaccines & Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global mRNA Vaccines & Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table mRNA Vaccines & Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Standardization Of Cancer Treatment MRNA Vaccine
Table Major Players of Standardization Of Cancer Treatment MRNA Vaccine
Figure Product Picture of Individualized Cancer Treatment MRNA Vaccine
Table Major Players of Individualized Cancer Treatment MRNA Vaccine
Figure Product Picture of Infectious Disease Treatment MRNA Vaccine
Table Major Players of Infectious Disease Treatment MRNA Vaccine
Figure Product Picture of Infection Prevention MRNA Vaccine
Table Major Players of Infection Prevention MRNA Vaccine
Table Global Consumption Sales by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global mRNA Vaccines & Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global mRNA Vaccines & Therapeutics Value Market Share by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sale Price by Type (2013-2018)
Figure mRNA Vaccines & Therapeutics Consumed in Infectious Disease
Figure Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2013-2018) (K Units)
Figure Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2013-2018) ($ Millions)
Figure Global Infectious Disease YoY Growth ($ Millions)
Figure mRNA Vaccines & Therapeutics Consumed in Cancer
Figure Global mRNA Vaccines & Therapeutics Market: Cancer (2013-2018) (K Units)
Figure Global mRNA Vaccines & Therapeutics Market: Cancer (2013-2018) ($ Millions)
Figure Global Cancer YoY Growth ($ Millions)
Figure mRNA Vaccines & Therapeutics Consumed in Other
Figure Global mRNA Vaccines & Therapeutics Market: Other (2013-2018) (K Units)
Figure Global mRNA Vaccines & Therapeutics Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Consumption Market Share by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Value by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Value Market Share by Application (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Value Market Share by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sale Price by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales by Players (2016-2018) (K Units)
Table Global mRNA Vaccines & Therapeutics Sales Market Share by Players (2016-2018)
Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Players in 2016
Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Players in 2017
Table Global mRNA Vaccines & Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Players in 2016
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Players in 2017
Table Global mRNA Vaccines & Therapeutics Sale Price by Players (2016-2018)
Figure Global mRNA Vaccines & Therapeutics Sale Price by Players in 2017
Table Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players mRNA Vaccines & Therapeutics Products Offered
Table mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global mRNA Vaccines & Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global mRNA Vaccines & Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global mRNA Vaccines & Therapeutics Consumption Market Share by Regions 2013-2018
Table Global mRNA Vaccines & Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global mRNA Vaccines & Therapeutics Value Market Share by Regions 2013-2018
Figure Global mRNA Vaccines & Therapeutics Value Market Share by Regions 2013-2018
Figure Americas mRNA Vaccines & Therapeutics Consumption 2013-2018 (K Units)
Figure Americas mRNA Vaccines & Therapeutics Value 2013-2018 ($ Millions)
Figure APAC mRNA Vaccines & Therapeutics Consumption 2013-2018 (K Units)
Figure APAC mRNA Vaccines & Therapeutics Value 2013-2018 ($ Millions)
Figure Europe mRNA Vaccines & Therapeutics Consumption 2013-2018 (K Units)
Figure Europe mRNA Vaccines & Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Value 2013-2018 ($ Millions)
Table Americas mRNA Vaccines & Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas mRNA Vaccines & Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas mRNA Vaccines & Therapeutics Consumption Market Share by Countries in 2017
Table Americas mRNA Vaccines & Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas mRNA Vaccines & Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas mRNA Vaccines & Therapeutics Value Market Share by Countries in 2017
Table Americas mRNA Vaccines & Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas mRNA Vaccines & Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas mRNA Vaccines & Therapeutics Consumption Market Share by Type in 2017
Table Americas mRNA Vaccines & Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas mRNA Vaccines & Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas mRNA Vaccines & Therapeutics Consumption Market Share by Application in 2017
Figure United States mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC mRNA Vaccines & Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC mRNA Vaccines & Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC mRNA Vaccines & Therapeutics Consumption Market Share by Countries in 2017
Table APAC mRNA Vaccines & Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC mRNA Vaccines & Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC mRNA Vaccines & Therapeutics Value Market Share by Countries in 2017
Table APAC mRNA Vaccines & Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC mRNA Vaccines & Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC mRNA Vaccines & Therapeutics Consumption Market Share by Type in 2017
Table APAC mRNA Vaccines & Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC mRNA Vaccines & Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC mRNA Vaccines & Therapeutics Consumption Market Share by Application in 2017
Figure China mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe mRNA Vaccines & Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe mRNA Vaccines & Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Consumption Market Share by Countries in 2017
Table Europe mRNA Vaccines & Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe mRNA Vaccines & Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Value Market Share by Countries in 2017
Table Europe mRNA Vaccines & Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe mRNA Vaccines & Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Consumption Market Share by Type in 2017
Table Europe mRNA Vaccines & Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe mRNA Vaccines & Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Consumption Market Share by Application in 2017
Figure Germany mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa mRNA Vaccines & Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa mRNA Vaccines & Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Application in 2017
Figure Egypt mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries mRNA Vaccines & Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries mRNA Vaccines & Therapeutics Value Growth 2013-2018 ($ Millions)
Table mRNA Vaccines & Therapeutics Distributors List
Table mRNA Vaccines & Therapeutics Customer List
Figure Global mRNA Vaccines & Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global mRNA Vaccines & Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global mRNA Vaccines & Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global mRNA Vaccines & Therapeutics Consumption Market Forecast by Regions
Table Global mRNA Vaccines & Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global mRNA Vaccines & Therapeutics Value Market Share Forecast by Regions
Figure Americas mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Americas mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure APAC mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure APAC mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Europe mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Europe mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure United States mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure United States mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Canada mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Canada mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure China mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure China mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Japan mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Japan mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Korea mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Korea mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure India mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure India mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Australia mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Australia mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Germany mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Germany mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure France mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure France mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure UK mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure UK mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Italy mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Italy mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Russia mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Russia mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Spain mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Spain mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Israel mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Israel mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries mRNA Vaccines & Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries mRNA Vaccines & Therapeutics Value 2018-2023 ($ Millions)
Table Global mRNA Vaccines & Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global mRNA Vaccines & Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global mRNA Vaccines & Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global mRNA Vaccines & Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global mRNA Vaccines & Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global mRNA Vaccines & Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global mRNA Vaccines & Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global mRNA Vaccines & Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Moderna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Moderna Therapeutics mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table CureVac Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CureVac mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table Translate Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Translate Bio mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table BioNTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure BioNTech mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table Sangamo Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sangamo Therapeutics mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table Argos Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table In-Cell-Art Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure In-Cell-Art mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table eTheRNA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure eTheRNA mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table Ethris Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ethris mRNA Vaccines & Therapeutics Market Share (2016-2018)
Table Tiba Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tiba Biotechnology mRNA Vaccines & Therapeutics Market Share (2016-2018)